Hong Kong: Impressive debut for Venus Medtech

Venus Medtech had a strong first day performance on the Hong Kong Stock exchange on Tuesday that saw its shares end the day up more than 30%. Last week the Hangzhou-based, transcatheter heart valve company raised HK$2.6bn (US$331m) after selling 78.5 million shares at the top of the HK$29 to HK$33 a share indicative range….

You must be a HMI Subscriber to view this content. Please log in or subscribe below.

Subscribe Now »